Glucokinase activators

Details for Australian Patent Application No. 2009246167 (hide)

Owner Takeda San Diego, Inc.

Inventors Wang, Haxia; Gwaltney, Stephen L.; Sabat, Mark; Tang, Mingnam; Jennings, Andrew John; Stafford, Jeffrey A; Cheruvallath, Zacharia

Agent Griffith Hack

Pub. Number AU-A-2009246167

PCT Pub. Number WO2009/140624

Priority 61/108,370 24.10.08 US; 61/054,052 16.05.08 US

Filing date 15 May 2009

Wipo publication date 19 November 2009

International Classifications

C07D 231/56 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

9 December 2010 PCT application entered the National Phase

  PCT publication WO2009/140624 Priority application(s): WO2009/140624

16 December 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 11 Nov 2010

27 September 2012 Alteration of Name

  The name of the applicant has been altered to Takeda California, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009246169-Long term disease modification using immunostimulatory oligonucleotides

2009246166-Anti-PSGL-1 antibodies and methods of identification and use